Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry).

Trial Profile

Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry).

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Aspirin (Primary) ; Clopidogrel (Primary)
  • Indications Coronary stent thrombosis
  • Focus Therapeutic Use
  • Acronyms VERIFRENCHY
  • Most Recent Events

    • 24 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top